Home › Post-COVID Conditions (Long COVID) › Virginia
Pag-aaral pangklinika para sa Post-COVID Conditions (Long COVID) sa Virginia
6 pag-aaral para sa Post-COVID Conditions (Long COVID) ang naghahanap ng mga kalahok sa mga site sa Virginia.
Opisyal na teksto ng pag-aaral (English)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Velocity Clinical Research - Hampton ( Site 3744), Hampton
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06667700Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Charlottesville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Velocity Clinical Research, Suffolk, Suffolk
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06679140A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Charlottesville
- GSK Investigational Site, Newport News
Nagre-recruitPhase 1
Edad 65 hanggang 85 · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT07464314Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- VCU Health System, Richmond
Nagre-recruitPhase 3
Lahat ng edad · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT03808922A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- Richard Bennett - Clinical Research Partners, Richmond
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
6 Months · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06585241Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.